CIEPLINSKA AGNIESZKA (VP FINANCE, CONTROLLER (PAO)) sold 14.9% of their position (940.00 shares) of MOMENTA PHARMACEUTICALS INC on the open market
Open‑market sale worth $28.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/15/2020ACC: 0001179110-20-007359
Officer· VP FINANCE, CONTROLLER (PAO)
Since Jan 2020
+5.36K
Net shares
Net buyer
$28.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.30K acquired · 940.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.15K
Price / share
—
Trade value
—
% of position
99.7%
6/11/2020
3.16K→6.31K
Common Stock
Direct
Shares
−940.00
Price / share
$30.15
Trade value
$28.34K
% of position
14.9%
6/12/2020
6.31K→5.37K
Total
Net shares
+2.21K
Net value
-$28.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2020 | A · Award | +3.15K | — | — | 99.7% | 3.16K | 6.31K |
| Common Stock Direct | 6/12/2020 | S · Sale | −940.00 | $30.15 | $28.34K | 14.9% | 6.31K | 5.37K |
| Total | +2.21K | -$28.34K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
3.15K shares
Shares
+3.15K
Strike price
Held after
6.30K
Exercisable
—
6/11/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.15K shares | 6/11/2020 | A · Award | +3.15K | — | 6.30K |